Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AACR 2022 | Applications of pepinemab in oncology and neurology

Terrence L. Fisher, PhD, Vaccinex Inc., Rochester, NY, discusses the wide applications of the monoclonal antibody, pepinemab, which is being trialled in the field of oncology, including head and neck cancer and non-small cell lung cancer (NSCLC), as well as in neurology, including Huntington’s Disease and Alzheimer’s Disease. This interview took place at the American Association for Cancer Research Annual Meeting 2022 in New Orleans, LA.